utahmedical8k012908.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date
of
Report (date of earliest event reported): January 29, 2008
Commission
File No. 0-11178
UTAH
MEDICAL PRODUCTS, INC.
(Exact
name of Registrant as specified in its charter)
UTAH
|
87-0342734
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.Employer
Identification
No.)
|
7043
South 300 West
Midvale,
Utah 84047
Address
of principal executive offices
Registrant's
telephone number: (801)
566-1200
ITEM
2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Attached
hereto as Exhibit 99.1 and incorporated by reference herein is financial
information for Utah Medical Products, Inc. for the quarter and twelve months
ended December 31, 2007 and forward-looking statements relating to 2008 and
beyond as presented in a press release dated January 29, 2008. The
information in this report shall be deemed incorporated by reference into any
registration statement heretofore or hereafter filed under the Securities Act
of
1933, as amended, except to the extent that such information is superseded
by
information as of a subsequent date that is included in or incorporated by
reference into such registration statement. The information in this report
shall
not be treated as filed for purposes of the Securities Exchange Act of 1934,
as
amended.
SIGNATURES
Pursuant
to the requirements of the Securities Exchanges Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
UTAH
MEDICAL PRODUCTS,
INC.
|
|
REGISTRANT
|
|
|
|
|
Date:
1/29/2008
|
By:
/s/
Kevin L.
Cornwell
|
|
Kevin L. Cornwell
|
|
CEO
|
Index
99.1
|
Financial
information for Utah Medical Products, Inc. for the quarter and
twelve
months ended December 31, 2007 and forward-looking statements relating
to
2008 and beyond as presented in a press release dated January 29,
2008.
|